杏林製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2011/08/11 | 1,544 | 1,582 | 1,538 | 1,576 | +7 | +0.4% | 135,000 |
2011/08/10 | 1,575 | 1,593 | 1,564 | 1,569 | +12 | +0.8% | 197,000 |
2011/08/09 | 1,535 | 1,565 | 1,535 | 1,557 | -13 | -0.8% | 337,000 |
2011/08/08 | 1,568 | 1,584 | 1,560 | 1,570 | -17 | -1.1% | 196,000 |
2011/08/05 | 1,575 | 1,593 | 1,558 | 1,587 | -35 | -2.2% | 187,000 |
2011/08/04 | 1,600 | 1,672 | 1,600 | 1,622 | +35 | +2.2% | 436,000 |
2011/08/03 | 1,579 | 1,604 | 1,576 | 1,587 | -3 | -0.2% | 175,000 |
2011/08/02 | 1,586 | 1,599 | 1,569 | 1,590 | +5 | +0.3% | 182,000 |
2011/08/01 | 1,605 | 1,606 | 1,570 | 1,585 | -22 | -1.4% | 395,000 |
2011/07/29 | 1,621 | 1,630 | 1,606 | 1,607 | -14 | -0.9% | 155,000 |
2011/07/28 | 1,611 | 1,625 | 1,604 | 1,621 | -17 | -1% | 148,000 |
2011/07/27 | 1,637 | 1,643 | 1,624 | 1,638 | +8 | +0.5% | 90,000 |
2011/07/26 | 1,638 | 1,639 | 1,626 | 1,630 | -14 | -0.9% | 96,000 |
2011/07/25 | 1,636 | 1,661 | 1,625 | 1,644 | +19 | +1.2% | 128,000 |
2011/07/22 | 1,626 | 1,635 | 1,624 | 1,625 | +1 | +0.1% | 94,000 |
2011/07/21 | 1,628 | 1,630 | 1,614 | 1,624 | -11 | -0.7% | 108,000 |
2011/07/20 | 1,650 | 1,658 | 1,630 | 1,635 | -11 | -0.7% | 148,000 |
2011/07/19 | 1,623 | 1,652 | 1,617 | 1,646 | +2 | +0.1% | 152,000 |
2011/07/15 | 1,631 | 1,648 | 1,631 | 1,644 | +13 | +0.8% | 182,000 |
2011/07/14 | 1,665 | 1,665 | 1,618 | 1,631 | -49 | -2.9% | 285,000 |
2011/07/13 | 1,640 | 1,692 | 1,640 | 1,680 | +40 | +2.4% | 273,000 |
2011/07/12 | 1,636 | 1,651 | 1,631 | 1,640 | -15 | -0.9% | 159,000 |
2011/07/11 | 1,628 | 1,663 | 1,628 | 1,655 | +28 | +1.7% | 240,000 |
2011/07/08 | 1,623 | 1,633 | 1,621 | 1,627 | +4 | +0.2% | 117,000 |
2011/07/07 | 1,633 | 1,633 | 1,613 | 1,623 | -18 | -1.1% | 179,000 |
2011/07/06 | 1,600 | 1,649 | 1,595 | 1,641 | +63 | +4% | 442,000 |
2011/07/05 | 1,560 | 1,582 | 1,560 | 1,578 | +6 | +0.4% | 82,000 |
2011/07/04 | 1,589 | 1,589 | 1,571 | 1,572 | -7 | -0.4% | 88,000 |
2011/07/01 | 1,590 | 1,590 | 1,569 | 1,579 | -19 | -1.2% | 200,000 |
2011/06/30 | 1,595 | 1,599 | 1,585 | 1,598 | +10 | +0.6% | 126,000 |
2011/06/29 | 1,579 | 1,594 | 1,574 | 1,588 | +10 | +0.6% | 143,000 |
2011/06/28 | 1,560 | 1,578 | 1,555 | 1,578 | +37 | +2.4% | 191,000 |
2011/06/27 | 1,546 | 1,554 | 1,514 | 1,541 | -22 | -1.4% | 201,000 |
2011/06/24 | 1,592 | 1,600 | 1,552 | 1,563 | +11 | +0.7% | 287,000 |
2011/06/23 | 1,540 | 1,558 | 1,540 | 1,552 | -5 | -0.3% | 145,000 |
2011/06/22 | 1,535 | 1,571 | 1,532 | 1,557 | +12 | +0.8% | 112,000 |
2011/06/21 | 1,555 | 1,560 | 1,537 | 1,545 | +4 | +0.3% | 124,000 |
2011/06/20 | 1,527 | 1,549 | 1,520 | 1,541 | +37 | +2.5% | 133,000 |
2011/06/17 | 1,538 | 1,540 | 1,504 | 1,504 | -45 | -2.9% | 274,000 |
2011/06/16 | 1,556 | 1,565 | 1,539 | 1,549 | -20 | -1.3% | 156,000 |
2011/06/15 | 1,576 | 1,578 | 1,552 | 1,569 | -17 | -1.1% | 193,000 |
2011/06/14 | 1,574 | 1,590 | 1,573 | 1,586 | +11 | +0.7% | 88,000 |
2011/06/13 | 1,571 | 1,586 | 1,566 | 1,575 | +4 | +0.3% | 66,000 |
2011/06/10 | 1,603 | 1,603 | 1,565 | 1,571 | -21 | -1.3% | 238,000 |
2011/06/09 | 1,563 | 1,592 | 1,563 | 1,592 | +25 | +1.6% | 197,000 |
2011/06/08 | 1,550 | 1,570 | 1,547 | 1,567 | +17 | +1.1% | 94,000 |
2011/06/07 | 1,540 | 1,550 | 1,540 | 1,550 | +10 | +0.6% | 124,000 |
2011/06/06 | 1,538 | 1,544 | 1,528 | 1,540 | +2 | +0.1% | 129,000 |
2011/06/03 | 1,534 | 1,541 | 1,517 | 1,538 | +3 | +0.2% | 257,000 |
2011/06/02 | 1,534 | 1,541 | 1,526 | 1,535 | -10 | -0.6% | 108,000 |
3251~
3300
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「杏林製薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
杏林製薬 | 148,800円 | +3.2% | +4.5% | 3.49% | 17.10倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
ゼリア新薬 | 222,600円 | +13.6% | +29.2% | 2.07% | 11.55倍 | 1.11倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
ネクセラファーマ | 112,900円 | +197.7% | - | 0.00% | 46.14倍 | 1.47倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
JCRファーマ | 71,100円 | -3.7% | -36.7% | 2.81% | 23.41倍 | 1.53倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
栄研化 | 210,400円 | +0.4% | -8.4% | 2.52% | 27.81倍 | 1.58倍 |
|
臨床検査薬大手。便潜血検査試薬(FIT)はシェア7割。尿検査(ウロ)、遺伝子検査も育成 |
市場注目の銘柄
チャート関連のコラム